{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:03:09Z","timestamp":1792206189643,"version":"4.4.0"},"reference-count":77,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2020R1A2C2005338"],"award-info":[{"award-number":["2020R1A2C2005338"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Carbapenem-resistant Acinetobacter baumannii (CRAB) infection has a high mortality rate, making the development of novel effective antibiotic therapeutic strategies highly critical. Antimicrobial peptides can outperform conventional antibiotics regarding drug resistance and broad-spectrum activity. PapMA, an 18-residue hybrid peptide, containing N-terminal residues of papiliocin and magainin 2, has previously demonstrated potent antibacterial activity. In this study, PapMA analogs were designed by substituting Ala15 or Phe18 with Ala, Phe, and Trp. PapMA-3 with Trp18 showed the highest bacterial selectivity against CRAB, alongside low cytotoxicity. Biophysical studies revealed that PapMA-3 permeabilizes CRAB membrane via strong binding to LPS. To reduce toxicity via reduced antibiotic doses, while preventing the emergence of multi-drug resistant bacteria, the efficacy of PapMA-3 in combination with six selected antibiotics was evaluated against clinical CRAB isolates (C1\u2013C5). At 25% of the minimum inhibition concentration, PapMA-3 partially depolarized the CRAB membrane and caused sufficient morphological changes, facilitating the entry of antibiotics into the bacterial cell. Combining PapMA-3 with rifampin significantly and synergistically inhibited CRAB C4 (FICI = 0.13). Meanwhile, combining PapMA-3 with vancomycin or erythromycin, both potent against Gram-positive bacteria, demonstrated remarkable synergistic antibiofilm activity against Gram-negative CRAB. This study could aid in the development of combination therapeutic approaches against CRAB.<\/jats:p>","DOI":"10.3390\/pharmaceutics13111800","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T23:24:42Z","timestamp":1635377082000},"page":"1800","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Development of Novel Peptides for the Antimicrobial Combination Therapy against Carbapenem-Resistant Acinetobacter baumannii Infection"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4286-8281","authenticated-orcid":false,"given":"Joonhyeok","family":"Choi","sequence":"first","affiliation":[{"name":"Department of Bioscience and Biotechnology, Konkuk University, Seoul 05029, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahjin","family":"Jang","sequence":"additional","affiliation":[{"name":"Department of Bioscience and Biotechnology, Konkuk University, Seoul 05029, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Kyung","family":"Yoon","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul 02841, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6438-4718","authenticated-orcid":false,"given":"Yangmee","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Bioscience and Biotechnology, Konkuk University, Seoul 05029, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S778","DOI":"10.1093\/clinids\/7.Supplement_4.S778","article-title":"Infections due to gram-negative bacteria: An overview","volume":"7","author":"Neu","year":"1985","journal-title":"Rev. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.mayocp.2014.12.002","article-title":"Emerging issues in gram-negative bacterial resistance: An update for the practicing clinician","volume":"90","author":"Vasoo","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jinf.2020.10.001","article-title":"The burden of bacteremic and non-bacteremic Gram-negative infections: A prospective multicenter cohort study in a low-resistance country","volume":"81","author":"Deelen","year":"2020","journal-title":"J. Infect."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jocn.2019.03.047","article-title":"The clinical characteristics of spontaneous Gram-negative bacterial meningitis in adults: A hospital-based study","volume":"64","author":"Lien","year":"2019","journal-title":"J. Clin. Neurosci."},{"key":"ref_6","unstructured":"World Health Organization (2017). Guidelines for the Prevention and Control of Carbapenem-Resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in Health Care Facilities, World Health Organization."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4103\/jms.jms_25_17","article-title":"World health organization releases global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics","volume":"32","author":"Shrivastava","year":"2018","journal-title":"J. Med Soc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jgar.2021.02.033","article-title":"Prevalence and molecular epidemiology of carbapenem-resistant Gram-negative bacilli and their resistance determinants in the Eastern Mediterranean Region over the last decade","volume":"25","author":"Sleiman","year":"2021","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/415389a","article-title":"Antimicrobial peptides of multicellular organisms","volume":"415","author":"Zasloff","year":"2002","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Wu, Q., Patocka, J., and Kuca, K. (2018). Insect Antimicrobial Peptides, a Mini Review. Toxins, 10.","DOI":"10.3390\/toxins10110461"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.2174\/138161209788682325","article-title":"The roles of antimicrobial peptides in innate host defense","volume":"15","author":"Diamond","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41573-019-0058-8","article-title":"Antimicrobial host defence peptides: Functions and clinical potential","volume":"19","author":"Mookherjee","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.peptides.2015.05.012","article-title":"Antimicrobial peptides: Possible anti-infective agents","volume":"72","author":"Narayana","year":"2015","journal-title":"Peptides"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrd3591","article-title":"Designing antimicrobial peptides: Form follows function","volume":"11","author":"Fjell","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10989-020-10110-x","article-title":"Antimicrobial Peptides as Potential Therapeutic Agents: A Review","volume":"27","author":"Datta","year":"2021","journal-title":"Int. J. Pept. Res. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1248\/cpb.c18-00380","article-title":"In Vitro Synergism and Anti-biofilm Activity of Quercetin-Pivaloxymethyl Conjugate against Staphylococcus aureus and Enterococcus Species","volume":"66","author":"Kim","year":"2018","journal-title":"Chem. Pharm. Bull."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1128\/AAC.00367-09","article-title":"Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii","volume":"54","author":"Pichardo","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Mgbeahuruike, E.E., Stalnacke, M., Vuorela, H., and Holm, Y. (2019). Antimicrobial and Synergistic Effects of Commercial Piperine and Piperlongumine in Combination with Conventional Antimicrobials. Antibiotics, 8.","DOI":"10.3390\/antibiotics8020055"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1111\/jam.15080","article-title":"Cytotoxicity and antimicrobial activity of synthetic peptides alone or in combination with conventional antimicrobials against fish pathogenic bacteria","volume":"131","author":"Assane","year":"2021","journal-title":"J. Appl. Microbiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.toxicon.2020.05.004","article-title":"Synergistic antimicrobial activity of melittin with clindamycin on the expression of encoding exfoliative toxin in Staphylococcus aureus","volume":"183","author":"Mahmoudi","year":"2020","journal-title":"Toxicon"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.micpath.2018.08.023","article-title":"Peptides as adjuvants for ampicillin and oxacillin against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"124","author":"Rishi","year":"2018","journal-title":"Microb. Pathog."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Shi, J., Chen, C., Wang, D., Tong, Z., Wang, Z., and Liu, Y. (2021). Amphipathic Peptide Antibiotics with Potent Activity against Multidrug-Resistant Pathogens. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13040438"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Gan, B.H., Cai, X., Javor, S., Kohler, T., and Reymond, J.L. (2020). Synergistic Effect of Propidium Iodide and Small Molecule Antibiotics with the Antimicrobial Peptide Dendrimer G3KL against Gram-Negative Bacteria. Molecules, 25.","DOI":"10.3390\/molecules25235643"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/psc.2978","article-title":"Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens","volume":"23","author":"Pollini","year":"2017","journal-title":"J. Pept. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/mdr.2018.0016","article-title":"Highly Synergistic Effects of Melittin with Conventional Antibiotics Against Multidrug-Resistant Isolates of Acinetobacter baumannii and Pseudomonas aeruginosa","volume":"25","author":"Akbari","year":"2019","journal-title":"Microb. Drug Resist."},{"key":"ref_26","first-page":"1119","article-title":"Cecropin A\u2014magainin 2 hybrid peptides having potent antimicrobial activity with low hemolytic effect","volume":"44","author":"Shin","year":"1998","journal-title":"Biochem. Mol. Biol. Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1399-3011.1997.tb01469.x","article-title":"Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 2 and cecropin A-melittin hybrid peptides","volume":"50","author":"Shin","year":"1997","journal-title":"J. Pept. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1034\/j.1399-3011.1999.00067.x","article-title":"NMR structural characterization of cecropin A(1-8)\u2014magainin 2(1-12) and cecropin A (1-8)\u2014melittin (1-12) hybrid peptides","volume":"53","author":"Oh","year":"1999","journal-title":"J. Pept. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1021\/acs.biochem.5b00392","article-title":"Peptoid-Substituted Hybrid Antimicrobial Peptide Derived from Papiliocin and Magainin 2 with Enhanced Bacterial Selectivity and Anti-inflammatory Activity","volume":"54","author":"Shin","year":"2015","journal-title":"Biochemistry"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Krishnan, M., Choi, J., Jang, A., and Kim, Y. (2020). A Novel Peptide Antibiotic, Pro10-1D, Designed from Insect Defensin Shows Antibacterial and Anti-Inflammatory Activities in Sepsis Models. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176216"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4014\/jmb.2011.11011","article-title":"Anti-Endotoxin 9-Meric Peptide with Therapeutic Potential for the Treatment of Endotoxemia","volume":"31","author":"Krishnan","year":"2021","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref_32","first-page":"1","article-title":"Cathelicidin LL-37: LPS-neutralizing, pleiotropic peptide","volume":"14","author":"Golec","year":"2007","journal-title":"Ann. Agric. Environ. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/bkcs.11277","article-title":"Short Antimicrobial Peptides Exhibiting Antibacterial and Anti-Inflammatory Activities Derived from the N-Terminal Helix of Papiliocin","volume":"38","author":"Jeon","year":"2017","journal-title":"Bull. Korean Chem. Soc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"12048","DOI":"10.1038\/srep12048","article-title":"Functional Roles of Aromatic Residues and Helices of Papiliocin in its Antimicrobial and Anti-inflammatory Activities","volume":"5","author":"Lee","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0732-8893(02)00473-X","article-title":"Comparison of methods of interpretation of checkerboard synergy testing","volume":"44","author":"Bonapace","year":"2002","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) (2000). Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. Clin. Microbiol. Infect., 6, 503\u2013508.","DOI":"10.1046\/j.1469-0691.2000.00149.x"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"112580","DOI":"10.1016\/j.ejmech.2020.112580","article-title":"Antimicrobial and anti-inflammatory activities of short dodecapeptides derived from duck cathelicidin: Plausible mechanism of bactericidal action and endotoxin neutralization","volume":"204","author":"Kumar","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1038\/s41598-019-40577-8","article-title":"Development of a novel short 12-meric papiliocin-derived peptide that is effective against Gram-negative sepsis","volume":"9","author":"Kim","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Jang, M., Kim, J., Choi, Y., Bang, J., and Kim, Y. (2019). Antiseptic Effect of Ps-K18: Mechanism of Its Antibacterial and Anti-Inflammatory Activities. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20194895"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.1046\/j.1432-1033.2001.02494.x","article-title":"Amphipathic alpha helical antimicrobial peptides","volume":"268","author":"Giangaspero","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10059-010-0050-y","article-title":"Characterization and cDNA cloning of a cecropin-like antimicrobial peptide, papiliocin, from the swallowtail butterfly, Papilio xuthus","volume":"29","author":"Kim","year":"2010","journal-title":"Mol. Cells"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1073\/pnas.84.15.5449","article-title":"Magainins, a class of antimicrobial peptides from Xenopus skin: Isolation, characterization of two active forms, and partial cDNA sequence of a precursor","volume":"84","author":"Zasloff","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/bip.360370206","article-title":"Structure-activity studies on magainins and other host defense peptides","volume":"37","author":"Maloy","year":"1995","journal-title":"Biopolymers"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1093\/bioinformatics\/btn392","article-title":"HELIQUEST: A web server to screen sequences with specific alpha-helical properties","volume":"24","author":"Gautier","year":"2008","journal-title":"Bioinformatics"},{"key":"ref_45","first-page":"215","article-title":"Imipenem and meropenem: Comparison of in vitro activity, pharmacokinetics, clinical trials and adverse effects","volume":"9","author":"Zhanel","year":"1998","journal-title":"Can. J. Infect. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0092-8674(01)00286-0","article-title":"Structural mechanism for rifampicin inhibition of bacterial rna polymerase","volume":"104","author":"Campbell","year":"2001","journal-title":"Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1128\/AAC.35.4.605","article-title":"Antibacterial activities and modes of action of vancomycin and related glycopeptides","volume":"35","author":"Nagarajan","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_48","unstructured":"Papich, M.G. (2016). Saunders Handbook of Veterinary Drugs: Small and Large Animal, Elsevier. [4th ed.]."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1128\/jb.95.3.1111-1117.1968","article-title":"Accumulation in gram-postive and gram-negative bacteria as a mechanism of resistance to erythromycin","volume":"95","author":"Mao","year":"1968","journal-title":"J. Bacteriol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jac\/14.suppl_D.7","article-title":"Mode of action and in-vitro activity of vancomycin","volume":"14","author":"Watanakunakorn","year":"1984","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.4049\/jimmunol.173.7.4652","article-title":"The antibiotic polymyxin B modulates P2X7 receptor function","volume":"173","author":"Ferrari","year":"2004","journal-title":"J. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Nation, R.L., Rigatto, M.H.P., Falci, D.R., and Zavascki, A.P. (2019). Polymyxin Acute Kidney Injury: Dosing and Other Strategies to Reduce Toxicity. Antibiotics, 8.","DOI":"10.3390\/antibiotics8010024"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jiph.2015.05.007","article-title":"In vitro antimicrobial synergy studies of carbapenem-resistant Acinetobacter baumannii isolated from intensive care units of a tertiary care hospital in Egypt","volume":"8","author":"Nageeb","year":"2015","journal-title":"J. Infect. Public Health"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"eaax1946","DOI":"10.1126\/sciadv.aax1946","article-title":"Omega76: A designed antimicrobial peptide to combat carbapenem- and tigecycline-resistant Acinetobacter baumannii","volume":"5","author":"Nagarajan","year":"2019","journal-title":"Sci. Adv."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00284-020-01949-w","article-title":"Synergistic Activity of Ceragenins Against Carbapenem-Resistant Acinetobacter baumannii Strains in Both Checkerboard and Dynamic Time-Kill Assays","volume":"77","author":"Inci","year":"2020","journal-title":"Curr. Microbiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0732-8893(00)00163-2","article-title":"Evaluation of antibiotic synergy against Acinetobacter baumannii: A comparison with Etest, time-kill, and checkerboard methods","volume":"38","author":"Bonapace","year":"2000","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fcimb.2017.00055","article-title":"Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options","volume":"7","author":"Lee","year":"2017","journal-title":"Front. Cell Infect. Microbiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"104922","DOI":"10.1016\/j.micpath.2021.104922","article-title":"Phenotypic and genotypic characteristics of Acinetobacter baumannii enrolled in the relationship among antibiotic resistance, biofilm formation and motility","volume":"155","author":"Zhang","year":"2021","journal-title":"Microb. Pathog."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"9431","DOI":"10.1038\/s41598-018-27504-z","article-title":"Validation of biofilm formation on human skin wound models and demonstration of clinically translatable bacteria-specific volatile signatures","volume":"8","author":"Ashrafi","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00203-014-0983-1","article-title":"Biofilm formation and persistence on abiotic surfaces in the context of food and medical environments","volume":"196","author":"Abdallah","year":"2014","journal-title":"Arch. Microbiol."},{"key":"ref_61","first-page":"119","article-title":"Biofilm formation in Acinetobacter baumannii","volume":"37","author":"Longo","year":"2014","journal-title":"New Microbiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/femsre\/fux010","article-title":"Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria","volume":"41","author":"Hall","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"41296","DOI":"10.1074\/jbc.M111.269225","article-title":"Structure and function of papiliocin with antimicrobial and anti-inflammatory activities isolated from the swallowtail butterfly, Papilio xuthus","volume":"286","author":"Kim","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cmi.2017.09.001","article-title":"New agents for the treatment of infections with Gram-negative bacteria: Restoring the miracle or false dawn?","volume":"23","author":"Wright","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.cmi.2019.03.014","article-title":"Carbapenem-resistant Acinetobacter baumannii: In pursuit of an effective treatment","volume":"25","author":"Piperaki","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s40265-014-0267-8","article-title":"Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections","volume":"74","author":"Viehman","year":"2014","journal-title":"Drugs"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ijantimicag.2016.09.014","article-title":"Synergistic combinations of polymyxins","volume":"48","author":"Lenhard","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jgar.2018.11.016","article-title":"Colistin monotherapy versus colistin\/rifampicin combination therapy in pneumonia caused by colistin-resistant Acinetobacter baumannii: A randomised controlled trial","volume":"17","author":"Park","year":"2019","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3934\/microbiol.2018.3.482","article-title":"An overview of the antimicrobial resistance mechanisms of bacteria","volume":"4","author":"Reygaert","year":"2018","journal-title":"AIMS Microbiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e000306","DOI":"10.1099\/mgen.0.000306","article-title":"Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii","volume":"5","author":"Hamidian","year":"2019","journal-title":"Microb. Genomics"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.3389\/fmicb.2019.02809","article-title":"Over-Expression of ISAba1-Linked Intrinsic and Exogenously Acquired OXA Type Carbapenem-Hydrolyzing-Class D-ss-Lactamase-Encoding Genes Is Key Mechanism Underlying Carbapenem Resistance in Acinetobacter baumannii","volume":"10","author":"Wong","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1021\/jm991031b","article-title":"Solution structure of polymyxins B and E and effect of binding to lipopolysaccharide: An NMR and molecular modeling study","volume":"42","author":"Pristovsek","year":"1999","journal-title":"J. Med. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"11498","DOI":"10.1074\/jbc.M806587200","article-title":"Interactions of lipopolysaccharide and polymyxin studied by NMR spectroscopy","volume":"284","author":"Mares","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"661195","DOI":"10.3389\/fmicb.2021.661195","article-title":"Antimicrobial Peptides Derived From Insects Offer a Novel Therapeutic Option to Combat Biofilm: A Review","volume":"12","author":"Sahoo","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1139\/cjm-2020-0142","article-title":"d-Amino acids in antimicrobial peptides: A potential approach to treat and combat antimicrobial resistance","volume":"67","author":"Kapil","year":"2021","journal-title":"Can. J. Microbiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bmc.2012.10.039","article-title":"Antimicrobial peptides containing unnatural amino acid exhibit potent bactericidal activity against ESKAPE pathogens","volume":"21","author":"Hicks","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Falanga, A., Nigro, E., De Biasi, M.G., Daniele, A., Morelli, G., Galdiero, S., and Scudiero, O. (2017). Cyclic Peptides as Novel Therapeutic Microbicides: Engineering of Human Defensin Mimetics. Molecules, 22.","DOI":"10.3390\/molecules22071217"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/13\/11\/1800\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:21:37Z","timestamp":1760167297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/13\/11\/1800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,27]]},"references-count":77,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["pharmaceutics13111800"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics13111800","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,27]]}}}